KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $569.0 million.

  • Gilead Sciences' Non Operating Income rose 8594.77% to $569.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $414.0 million, marking a year-over-year increase of 2358.21%. This contributed to the annual value of $6.0 million for FY2024, which is 9696.97% down from last year.
  • Gilead Sciences' Non Operating Income amounted to $569.0 million in Q3 2025, which was up 8594.77% from $208.0 million recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Non Operating Income ranged from a high of $569.0 million in Q3 2025 and a low of -$369.0 million during Q1 2021
  • Over the past 5 years, Gilead Sciences' median Non Operating Income value was -$72.0 million (recorded in 2023), while the average stood at -$29.7 million.
  • Per our database at Business Quant, Gilead Sciences' Non Operating Income skyrocketed by 303000.0% in 2023 and then plummeted by 46043.96% in 2025.
  • Over the past 5 years, Gilead Sciences' Non Operating Income (Quarter) stood at $57.0 million in 2021, then crashed by 117.54% to -$10.0 million in 2022, then soared by 3030.0% to $293.0 million in 2023, then plummeted by 111.95% to -$35.0 million in 2024, then soared by 1725.71% to $569.0 million in 2025.
  • Its last three reported values are $569.0 million in Q3 2025, $208.0 million for Q2 2025, and -$328.0 million during Q1 2025.